BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 31954639)

  • 1. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis.
    Velangi PS; Chen KA; Kazmirczak F; Okasha O; von Wald L; Roukoz H; Farzaneh-Far A; Markowitz J; Nijjar PS; Bhargava M; Perlman D; Akçakaya M; Shenoy C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1395-1405. PubMed ID: 31954639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of RV Abnormalities on CMR in Patients With Known or Suspected Cardiac Sarcoidosis.
    Wang J; Zhang J; Hosadurg N; Iwanaga Y; Chen Y; Liu W; Wan K; Patel AR; Wicks EC; Gkoutos GV; Han Y; Chen Y
    JACC Cardiovasc Imaging; 2023 Mar; 16(3):361-372. PubMed ID: 36752447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
    Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
    Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
    Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM
    ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
    Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
    JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and prognostic value of right ventricular (dys)function in patients with non-ischaemic dilated cardiomyopathy assessed with cardiac magnetic resonance imaging.
    Becker MAJ; van der Lingen ACJ; Wubben M; van de Ven PM; van Rossum AC; Cornel JH; Allaart CP; Germans T
    ESC Heart Fail; 2021 Apr; 8(2):1055-1063. PubMed ID: 33560582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.
    Freed BH; Gomberg-Maitland M; Chandra S; Mor-Avi V; Rich S; Archer SL; Jamison EB; Lang RM; Patel AR
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):11. PubMed ID: 22296860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.
    Hulten E; Agarwal V; Cahill M; Cole G; Vita T; Parrish S; Bittencourt MS; Murthy VL; Kwong R; Di Carli MF; Blankstein R
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005001. PubMed ID: 27621357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic value of right ventricular dysfunction on cardiovascular magnetic resonance imaging in anthracycline-treated cancer survivors.
    Chhikara S; Hooks M; Athwal PSS; Hughes A; Ismail MF; Joppa S; Velangi PS; Nijjar PS; Blaes AH; Shenoy C
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1222-1230. PubMed ID: 34297807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.
    Stevenson A; Bray JJH; Tregidgo L; Ahmad M; Sharma A; Ng A; Siddiqui A; Khalid AA; Hylton K; Ionescu A; Providencia R; Kirresh A
    JACC Cardiovasc Imaging; 2023 Mar; 16(3):345-357. PubMed ID: 36752432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis.
    Magnocavallo M; Vetta G; Polselli M; Cauti FM; Parlavecchio A; Caminiti R; Crea P; Pannone L; Sorgente A; Chimenti C; Chierchia GB; Rossi P; Natale A; de Asmundis C; Bianchi S; Della Rocca DG
    J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1781-1784. PubMed ID: 37493490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.
    Wan K; Sun J; Han Y; Luo Y; Liu H; Yang D; Cheng W; Zhang Q; Zeng Z; Chen Y
    Heart Vessels; 2018 Feb; 33(2):170-179. PubMed ID: 28840397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevalence, Correlates, and Impact on Cardiac Mortality of Right Ventricular Dysfunction in Nonischemic Cardiomyopathy.
    Pueschner A; Chattranukulchai P; Heitner JF; Shah DJ; Hayes B; Rehwald W; Parker MA; Kim HW; Judd RM; Kim RJ; Klem I
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt B):1225-1236. PubMed ID: 29025576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
    Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right Ventricular Dysfunction and the Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Hammer-Hansen S; Voges I; Nyktari E; Raja AA; Svendsen JH; Pehrson S; Signorovitch J; Køber LV; Prasad SK; Thune JJ
    Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007022. PubMed ID: 30866666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.
    Mikami Y; Jolly U; Heydari B; Peng M; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Lydell CP; Howarth AG; Yee R; White JA
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28087564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Right Ventricular Function in Patients With Suspected Myocarditis Undergoing Cardiac Magnetic Resonance.
    Bernhard B; Schnyder A; Garachemani D; Fischer K; Tanner G; Safarkhanlo Y; Stark AW; Schütze J; Pavlicek-Bahlo M; Greulich S; Johner C; Wahl A; Benz DC; Kwong RY; Gräni C
    JACC Cardiovasc Imaging; 2023 Jan; 16(1):28-41. PubMed ID: 36599567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
    Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
    J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.